ES102

ES102 · Elpiscience (Suzhou) Biopharma, Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ES102, covering 2025-06-23 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer [Phase 2]